Back to results
US 2024/0226040 A1Published application
Solid pharmaceutical tablet
AssigneeGenexa Inc.
InventorsMax Spielberg, David Johnson
Life of this patent
Estimating the term…
Abstract
A tablet includes an active material and a base material comprising carnauba wax and an oil. A tablet formulation can contain an active pharmaceutical ingredient and a base material that includes carnauba wax. The carnauba wax constitutes more than 50% of the base material.
Claims34
A tablet formulation comprising:
- (a) an active pharmaceutical ingredient, and (b) a base material comprising carnauba wax, wherein the carnauba wax constitutes more than 50% of the base material, and is between 50 and 80% by weight of the base material, with the active agent constituting more than 90% by weight of the tablet, and wherein the hardness of the tablet formulation is between 50N and 90N.
A method of forming a tablet, comprising:
- (a) preparing a base material of carnauba wax and an active pharmaceutical ingredient, wherein the active agent is granulated;
- (b) combining the base material and the active pharmaceutical ingredient into a mixture;
- and (c) compressing said combined mixture into a tablet.
A base material for a tablet comprising:
- (a) carnauba wax and (b) an oil, wherein the carnauba wax is greater than 50% of the base material.
A tablet formulation comprising essentially:
- (a) an active material comprising an active pharmaceutical ingredient, and (b) a base material comprising carnauba wax and an oil, wherein the carnauba wax is between 50 and 80% by weight of the base material, and the active agent is greater than 90% by weight of the tablet, wherein the hardness of the tablet formulation is between 50N and 90N.
Dependencies are inferred from the claim text.